The Role of Group II Metabotropic Glutamate Receptors in the Striatum in Electroacupuncture Treatment of Parkinsonian Rats

CNS Neurosci Ther. 2017 Jan;23(1):23-32. doi: 10.1111/cns.12587. Epub 2016 Jul 14.

Abstract

Aims: Glutamatergic transmission may play a critical role in the pathogenesis of Parkinson's disease (PD). Electroacupuncture (EA) has been demonstrated to effectively alleviate PD symptoms. In this study, a potential glutamate-dependent mechanism underlying the therapeutic action of EA was investigated.

Methods: The effects of EA stimulation on motor behaviors, dopamine contents, glutamate release, and group II metabotropic glutamate receptor (mGluR2/3) expression in unilateral 6-hydroxydopamine (6-OHDA)-lesioned rats were examined.

Results: Unilateral 6-OHDA lesions of the nigrostriatal system caused a marked increase in glutamate content in the ipsilateral cortex and striatum. mGluR2/3 protein expression and mGluR3 mRNA expression were reduced in the striatum. Noticeably, prolonged EA stimulation at 100 Hz significantly reversed these changes in the striatal glutamate system. Behaviorally, EA improved the motor deficits induced by 6-OHDA lesions. Intrastriatal infusion of an mGluR2/3 antagonist APICA blocked the improving effect of EA.

Conclusions: These data collectively demonstrate that the group II mGluR-mediated glutamatergic transmission in the striatum is sensitive to dopamine depletion and may serve as a substrate of EA for mediating the therapeutic effect of EA in a rat model of PD.

Keywords: Basal ganglia circuit; Electroacupuncture; Glutamate; Parkinson's disease; mGluR.

MeSH terms

  • Analysis of Variance
  • Animals
  • Chromatography, High Pressure Liquid
  • Corpus Striatum / metabolism*
  • Disease Models, Animal
  • Electroacupuncture*
  • Excitatory Amino Acid Agents / pharmacology
  • Gene Expression Regulation / physiology
  • Glutamic Acid / metabolism
  • Male
  • Motor Activity / physiology
  • Oxidopamine / toxicity
  • Parkinsonian Disorders / chemically induced
  • Parkinsonian Disorders / pathology*
  • Parkinsonian Disorders / physiopathology
  • Parkinsonian Disorders / therapy*
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Metabotropic Glutamate / genetics
  • Receptors, Metabotropic Glutamate / metabolism*
  • Sympatholytics / toxicity
  • Time Factors
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Excitatory Amino Acid Agents
  • RNA, Messenger
  • Receptors, Metabotropic Glutamate
  • Sympatholytics
  • Glutamic Acid
  • Oxidopamine
  • Tyrosine 3-Monooxygenase